Sentien's mission is to harness the power of cell therapy with innovative drug delivery systems to treat a wide range of acute inflammatory diseases. Our lead product is designed to allow for controlled, sustained delivery of mesenchymal stem cell (MSC) secreted factors. This approach immobilizes the MSCs in an extracorporeal device, allowing for doses of therapeutic secreted factors that are unattainable by direct injection.